TRIP13 and hepatocellular carcinoma: Trip13 protein levels were consistently increased in tumor tissue compared to nontumor liver tissue from the same patients (Figure 1D and Figure S1B (Supporting Information)), demonstrating that the SAC‐regulating[18] Trip13 represents a highly deregulated component in the pathophysiology of human and mouse HCC.